Circulation-Heart Failure

Article	Citations
Two-Year Follow Up of the LATERAL Clinical Trial	149
Social Determinants of Health and Disparities in Guideline-Directed Medical Therapy Optimization for Heart Failure	132
Unraveling Comorbidities Contribution to Cardiac Diastolic Dysfunction and Heart Failure	83
Mavacamten: Real-World Experience From 22 Months of the Risk Evaluation and Mitigation Strategy (REMS) Program	64
Unraveling the Role of Myocardial Inflammation in ATTR-CM: A Targetable Mechanism?	61
Systemic Circulation in Advanced Heart Failure and Cardiogenic Shock: State-of-the-Art Review	60
Letter by Jha Regarding Article, “Pathophysiologic Vasodilation in Cardiogenic Shock and Its Impact on Mortality”	59
Plasma SVEP1 Levels Predict Cardiovascular Events in Hypertrophic Cardiomyopathy Beyond Conventional Clinical Risk Models Including NT-proBNP	49
Levels of Trimethylamine N-Oxide Remain Elevated Long Term After Left Ventricular Assist Device and Heart Transplantation and Are Independent From Measures of Inflammation and Gut Dysbiosis	46
Proteomic Analysis of Effects of Spironolactone in Heart Failure With Preserved Ejection Fraction	42
Proposed Cardiac End Points for Clinical Trials in Immunoglobulin Light Chain Amyloidosis: Report From the Amyloidosis Forum Cardiac Working Group	41
It’s Not You, It’s Me: Uncovering Heart-Kidney Relationship Failures	40
Cardiogenic Shock From Heart Failure Versus Acute Myocardial Infarction: Clinical Characteristics, Hospital Course, and 1-Year Outcomes	40
Early Outcomes in Patients With LVAD Undergoing Heart Transplant via Use of the SherpaPak Cardiac Transport System	40
Longitudinal Invasive Hemodynamic Assessment in Patients With Acute Decompensated Heart Failure–Related Cardiogenic Shock: A Single-Center Experience	38
Edge-to-Edge Transcatheter Mitral Valve Repair Versus Optimal Medical Treatment in Nonresponders to Cardiac Resynchronization Therapy: The MITRA-CRT Trial	38
SUSTAINing the Care of Patients With Advanced Heart Failure by Supporting Family Caregivers	37
Temporary Mechanical Circulatory Support Coordinator: Conception and Implementation of a Novel Role	37
Safety and Tolerability of Angiotensin Receptor-Neprilysin Inhibitor Initiation in High-Risk Acute Myocardial Infarction Relative to Care Setting: A Subgroup Analysis of the PARADISE-MI Trial	36
REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic LMNA -Related Dilated Cardiomyopathy	35
Challenges for Patients Dying of Heart Failure and Cancer	35
Diurnal Variations in Natriuretic Peptide Levels: Clinical Implications for the Diagnosis of Acute Heart Failure	35
Why We Should Care About Who Cares for Patients With Heart Failure With Preserved Ejection Fraction	35
Diastolic Dysfunction Is Unmasked on Exercise in Patients With Asymptomatic, Severe Aortic Stenosis: An Invasive Hemodynamic Study	34
Finerenone Improves Outcomes in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction Irrespective of Age: A Prespecified Analysis of FINEARTS-HF	33

High-Intensity Care Versus GDMT Titration: Which Rapidly Improves Health Status in Patients With Heart Failure?	32
Myosin-Inhibitor Mavacamten Acutely Enhances Cardiomyocyte Diastolic Compliance in Heart Failure With Preserved Ejection Fraction	32
Effect of Dapagliflozin on Accelerometer-Based Measures of Physical Activity in Patients With Heart Failure: An Analysis of the DETERMINE Trials	32
Trending Cardiac Biomarkers During Pregnancy in Women With Cardiovascular Disease	31
GDMT Optimization, But Make It Patient-Centered: Understanding Patient Needs During Heart Failure Medication Discussions	31
Sex-Specific Clinical Outcomes of the PACT-HF Randomized Trial	31
Background Medical Therapy and Clinical Outcomes From the VICTORIA Trial	31
Association of Health Insurance Payer Type and Outcomes After Durable Left Ventricular Assist Device Implantation: An Analysis of the STS-INTERMACS Registry	30
Outcomes of Combined Heart and Kidney Transplantation Under the New Heart Allocation Policy: A United Organ Network for Organ Sharing Database Analysis	30
Long-Axis Biplane Echocardiography Sensitively Detects the Progressing Functional Deterioration of Mouse Heart	29
Longitudinal Trends in Donor and Recipient Risk Profile, and Clinical Outcomes, for Donation After Circulatory Death Heart Transplantation	29
Hierarchical End Points in Prior Heart Failure Trials and the HEART-FID Trial	29
Rare Etiology of Cardiogenic Shock in Pregnancy	29
Case Implementing 2022 AHA/ACC/HFSA Guidelines: Heart Failure Management in Pregnancy: Early Planning, Close Surveillance, and Multidisciplinary Care	28
2021: A Look Back	28
Peripheral Venous Pressure: An Important but Neglected Contributor to Echocardiographic Estimation of Pulmonary Artery Pressure With Exercise	27
Physiologic Insights Into Long COVID Breathlessness	27
Response by Kremer et al to Letter Regarding Article, “Acute Impact of Prone Positioning on the Right Ventricle in COVID-19–Associated Acute Respiratory Distress Syndrome”	27
Physical Activity, Sedentary Time, and Heart Failure Risk in Low-Income Black and White Adults Living in the Southeastern United States	26
Potential Novel Therapeutic Target to Improve Graft Survival: New Insights Into the Role of Checkpoint Molecules in Heart Transplant Rejection	26
Are Men and Women That Different?	26
Response by Liang and Shimada to Letter Regarding Article “Comprehensive Proteomics Profiling Reveals Circulating Biomarkers of Hypertrophic Cardiomyopathy”	26
Proteomic Biomarkers of Sacubitril/Valsartan Treatment Response in Heart Failure With Preserved Ejection Fraction: Molecular Insights Into Sex Differences	26
Temporal Trends and Prognosis of Physical Examination Findings in Patients With Acute Decompensated Heart Failure: The ARIC Study Community Surveillance	26
Letter by Qiu and Du Regarding Article, “Sodium Restriction in Patients With Heart Failure: A Systematic Review and Meta-Analysis of Randomized Clinical Trials”	25
Circulating MicroRNAs Identify Early Phenotypic Changes in Sarcomeric Hypertrophic Cardiomyopathy	25
Cardiac Rehabilitation Among Hospitalized Patients With Heart Failure: Eligibility, Enrollment, and Participation	25
Response by Colin-Ramirez et al to Letter Regarding Article, “Sodium Restriction in Patients With Heart Failure: A Systematic Review and Meta-Analysis of Randomized Clinical Trials”	24
Shifting the Shadow of Death	23
Characteristics of United States Counties in Which Heart Failure Clinical Trials of Pharmacotherapy Were Conducted	23
Acute Pulmonary Edema During Impella RP Support: Too Much of a Good Thing	23
Natriuretic Peptide Guidance for Post-Myocardial Infarction Care: An Opportunity to Prevent Heart Failure Progression	23
Case of High Output Heart Failure Caused by Renal Clear Cell Carcinoma	22
Association of Pulmonary Artery Pulsatility Index With Adverse Cardiovascular Events Across a Hospital-Based Sample	21
Impact of Insulin Treatment on the Effect of Eplerenone: Insights From the EMPHASIS-HF Trial	21
Blood Pressure Drops During Hospitalization for Acute Heart Failure Treated With Serelaxin: A Patient-Level Analysis of 4 Randomized Controlled Trials	21
Impact of Different Training Modalities on Molecular Alterations in Skeletal Muscle of Patients With Heart Failure With Preserved Ejection Fraction: A Substudy of the OptimEx Trial	21
Obesity Is a Heavy Load in Cardiogenic Shock and Mechanical Circulation	21
Impact of Blood Pressure Targets in Patients With Heart Failure Undergoing Postresuscitation Care: A Subgroup Analysis From a Randomized Controlled Trial	20
Long-Term Outcomes of Early Coronary Artery Disease Testing After New-Onset Heart Failure	20
Pathological Evidence of Native Aortic Valve Injury After Impella Support	19
Calling for Cooperation and Collaboration in Adult Congenital Heart Disease–Related Heart Failure	19
Cardiovascular Measures of All-Cause Mortality in Duchenne Muscular Dystrophy	19
Biopsy-Proven Giant Cell Myocarditis Following the COVID-19 Vaccine	19
Tranexamic Acid in the Treatment of Refractory Gastrointestinal Arteriovenous Malformation Bleeding in Left Ventricular Assist Device Patients	19
PRKAG2 Syndrome Caused by a Novel Missense Variant Mimicked Sporadic Hypertrophic Cardiomyopathy Until Its Progression to Burned-Out Phase	18
Epidemiology of Cardiogenic Shock in Hospitalized Adults With COVID-19: A Report From the American Heart Association COVID-19 Cardiovascular Disease Registry	18
Protein Biomarkers of Adverse Clinical Features and Events in Sarcomeric Hypertrophic Cardiomyopathy	18
Hemodynamic Effects of Cyclic Guanosine Monophosphate-Dependent Signaling Through β3 Adrenoceptor Stimulation in Patients With Advanced Heart Failure: A Randomized Invasive Clinical Trial	18
How Did We Score? Evaluating the Utility of a Score-Based System for Heart Failure Medical Therapy	17

Serial 99m Technetium Pyrophosphate Scintigraphy and Multimodality Assessments After Different Doses of Tafamidis for Variant Transthyretin Cardiac Amyloidosis	17
Mode of Death in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF Trial	17
Ramping Up the Pressure on the Right Ventricle	17
Avoiding Catastrophe	17
Impact of Tafamidis and Optimal Background Treatment on Physical Performance in Patients With Transthyretin Amyloid Cardiomyopathy	17
Comparing New York Heart Association Class and Patient-Reported Outcomes Among Patients Hospitalized for Heart Failure	17
Change in Caregiver Health-Related Quality of Life From Before to Early After Surgery: SUSTAIN-IT Study	17
Identifying Discordance of Right- and Left-Ventricular Filling Pressures in Patients With Heart Failure by the Clinical Examination	17
Could a Low-Dose Diuretic Polypill Improve Outcomes in Heart Failure With Preserved Ejection Fraction?	16
Modulation of Pulsatile Left Ventricular Afterload by Renal Denervation in Heart Failure With Preserved Ejection Fraction	16
Letter by Monda and Limongelli Regarding Article, “Changes in Cardiac Function Following Fulminant Myocarditis”	16
Trends and Outcomes Associated With Bariatric Surgery and Pharmacotherapies With Weight Loss Effects Among Patients With Heart Failure and Obesity	16
Increased Risk of Congestive Heart Failure Following Carbon Monoxide Poisoning	16
Early Reduction in Ambulatory Pulmonary Artery Pressures After Initiation of Sacubitril/Valsartan	16
Epicardial Fat Paradox and Differential Effects of GLP-1 Receptor Agonists Across Heart Failure Phenotypes	15
A Peek Into the Future: Will Serial Multimarker Testing Help Bring a New Era of Precision Medicine in Heart Failure Patients?	15
SPECTRA Phase 2b Study: Impact of Sotatercept on Exercise Tolerance and Right Ventricular Function in Pulmonary Arterial Hypertension	15
Nonpharmacological Approaches to Managing Heart Failure With Preserved Ejection Fraction	15
Equity in Heart Failure Care: A Get With the Guidelines Analysis of Between- and Within-Hospital Differences in Care by Sex, Race, Ethnicity, and Insurance	15
Prognostic Value of Elevated Levels of Plasma N-Acetylneuraminic Acid in Patients With Heart Failure	15
Infarct Size Reduction With Cyclosporine A in Circulatory Death Rat Hearts: Reducing Effective Ischemia Time With Therapy During Reperfusion	15
Pitfalls in Using Estimated Glomerular Filtration Rate Slope as a Surrogate for the Effect of Drugs on the Risk of Serious Adverse Renal Outcomes in Clinical Trials of Patients With Heart Failure	15
Identifying the Mechanisms of a Peripherally Limited Exercise Phenotype in Patients With Heart Failure With Preserved Ejection Fraction	15
Metabolically Healthy/Unhealthy Overweight/Obesity Associations With Incident Heart Failure in Postmenopausal Women	15
Common Variants on FGD5 Increase Hazard of Mortality or Rehospitalization in Patients With Heart Failure From the ASCEND-HF Trial	15
Association Between Angiotensin Receptor–Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction	15
Disparities in Hospital Length of Stay Across Race and Ethnicity Among Patients With Heart Failure	14
Pulmonary Hypertension in Congenital Heart Disease: A Scientific Statement From the American Heart Association	14
Plasma Proteomic Patterns Show Sex Differences in Early Concentric Left Ventricular Remodeling	14
Pathophysiologic Vasodilation in Cardiogenic Shock and Its Impact on Mortality	14
Immunomodulatory Cell Therapy Using αGalCer-Pulsed Dendritic Cells Ameliorates Heart Failure in a Murine Dilated Cardiomyopathy Model	14
Practice Patterns and Patient Outcomes After Widespread Adoption of Remote Heart Failure Care	14
Adverse Outcomes Associated With Interleukin-6 in Patients Recently Hospitalized for Heart Failure With Preserved Ejection Fraction	14
Pleural Effusion and Invasive Hemodynamic Measurements in Advanced Heart Failure	14
Early Outcomes of Heart Transplantation Using Donation After Circulatory Death Donors in the United States	14
Left Ventricular Gene Expression in Heart Failure With Preserved Ejection Fraction—Profibrotic and Proinflammatory Pathways and Genes	14
Nitric Oxide–Mediated Coronary Endothelial Function Is Impaired in Patients With Heart Failure With Preserved Ejection Fraction	14
Reflections on the Win Ratio With Time-to-Event Outcomes	14
Social Determinants of Health and 30-Day Readmissions Among Adults Hospitalized for Heart Failure in the REGARDS Study	13
Synergistic Impact of Systolic Blood Pressure and Perfusion Status on Mortality in Acute Heart Failure	13
Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy	13
Framework to Classify Reverse Cardiac Remodeling With Mechanical Circulatory Support: The Utah-Inova Stages	13
Heart Failure Spending Function: An Investment Framework for Sequencing and Intensification of Guideline-Directed Medical Therapies	13
The Great Masquerader: Diagnosing Cardiac Sarcoidosis in the Era of Advanced Cardiac Imaging	13
Race- and Sex-Specific Population Attributable Fractions of Incident Heart Failure	12
Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial Hypertension	12
Predictive Modeling to Assess Pretest Probability of Transthyretin Gene Variants Based on Demographic Information	12
Microvascular Dysfunction as a Possible Link Between Heart Failure and Cognitive Dysfunction	12
Effect of Empagliflozin as an Add-On Therapy on Decongestion and Renal Function in Patients With Diabetes Hospitalized for Acute Decompensated Heart Failure	12
Correction to: Diagnosis and Treatment of Right Heart Failure in Pulmonary Vascular Diseases: A National Heart, Lung, and Blood Institute Workshop	12
Risk Factors and Outcomes Associated With Heart Failure With Preserved and Reduced Ejection Fraction in People With Chronic Kidney Disease	12
Ongoing Enigma of NT-proBNP in HFpEF: Insights From Proteomics	12
Rethinking Donor and Recipient Risk Matching in Europe and North America: Using Heart Transplant Predictors of Donor and Recipient Risk	12
Targeting Iron Deficiency in Heart Failure: Existing Evidence and Future Expectations	12
Cognitive and Procedural Competencies in the Cardiac Intensive Care Unit	12
Novel Trial Design: CHIEF-HF	12
Clinical Characteristics and Predictors of In-Hospital Mortality in Patients With Cardiogenic Shock: Results From the RESCUE Registry	12
Effect of Empagliflozin on Blood Volume Redistribution in Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the Empire HF Randomized Clinical Trial	12
Stress and Coping Among Family Caregivers of Patients With a Destination Therapy Left Ventricular Assist Device: A Multicenter Mixed Methods Study	12
Heart Failure With Preserved Ejection Fraction: From a Vascular Perspective	12
Response by Denfeld et al to Letter Regarding Article, “Characterizing Sex Differences in Physical Frailty Phenotypes in Heart Failure”	12
Temporal Trends of Heart Failure Hospitalizations in Cardiology Versus Noncardiology Wards According to Ejection Fraction: 16-Year Data From the SwedeHF Registry	11
Long-Term Electrocardiographic and Echocardiographic Progression of Arrhythmogenic Right Ventricular Cardiomyopathy and Their Correlation With Ventricular Tachyarrhythmias	11
Transforming Growth Factor-β Analysis of the VANISH Trial Cohort	11
Metabolic Profiling Identifies 1-MetHis and 3-IPA as Potential Diagnostic Biomarkers for Patients With Acute and Chronic Heart Failure With Reduced Ejection Fraction	11
Early Use of Phosphodiesterase Inhibitors After Left Ventricular Assist Device: Is It Time to Rethink?	11
Sex and Age Differences in the Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Heart Failure: A Prospective Cohort Study	11
Clinical Outcomes Associated With Acute Mechanical Circulatory Support Utilization in Heart Failure Related Cardiogenic Shock	11
MiR-150 Attenuates Maladaptive Cardiac Remodeling Mediated by Long Noncoding RNA MIAT and Directly Represses Profibrotic Hoxa4	11
Risk-Based Approach for the Prediction and Prevention of Heart Failure	11
You Are Where You Eat: The Local Environment and Risk of Heart Failure	11
Response by Park et al to Letter Regarding Article, “Transcriptomic Analysis of Right Ventricular Remodeling in Two Rat Models of Pulmonary Hypertension: Identification and Validation of Epithelial-to	11
Correction to: Effect of Empagliflozin as an Add-On Therapy on Decongestion and Renal Function in Patients With Diabetes Hospitalized for Acute Decompensated Heart Failure: A Prospective Randomized Co	11
Management of Hypertension in Patients With Ventricular Assist Devices: A Scientific Statement From the American Heart Association	11
AHA/ACC/HFSA Guidelines Implementation Case Series: Resynchronization Pacing Preferred in Patients With Reduced Ejection Fraction	11
Rethinking the Nomenclature of Heart Failure Cardiogenic Shock: Do We Need to Start De Novo?	11
Letter by Baldovino et al Regarding Article, “Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy”	11
Social Constructs and the Making of Social Determinants of Health: A Pathway for Equity Interventions to Change Heart Failure Outcomes	10
Psychometric Evaluation of the Kansas City Cardiomyopathy Questionnaire in Men and Women With Heart Failure	10
Coronary Allograft Vasculopathy: From Predictably Unpredictable to Unpredictably Predictable	10

Predicting 1-Year Mortality in Outpatients With Heart Failure With Reduced Left Ventricular Ejection Fraction: Do Empiric Models Outperform Physician Intuitive Estimates? A Multicenter Cohort Study	10
Conceptualizing Liberation From Venoarterial Extracorporeal Membrane Oxygenation	10
Is There a Logic in Using Device-Based Algorithms to Prevent Heart Failure Decompensations?	10
Predicted Heart Mass: A Tale of 2 Ventricles	10
Response by Marquetand and Reil to Letter Regarding Article, “Invasive and Echocardiographic Characteristics of a Patient With Severe Pulmonary Valve Regurgitation Pretending Severe Pulmonary Stenosis	10
Cardiomyopathy and Refractory Tachycardia in a Patient With Hereditary Amyloidosis	10
Ventricular Systolic Discordance Post-Premature Ventricular Complex in Constrictive Pericarditis	9
Is My Patient Fit for Surgery? Navigating Between the Rock of Heart Failure and the Hard Place of Semiurgent Surgery	9
Identification of Clinical Drivers of Left Atrial Enlargement Through Genomics of Left Atrial Size	9
Transferrin Saturation, Serum Iron, and Ferritin in Heart Failure: Prognostic Significance and Proteomic Associations	9
Enhancing the Prediction of Cardiac Allograft Vasculopathy Using Intravascular Ultrasound and Machine Learning: A Proof of Concept	9
In-Hospital Virtual Peer-to-Peer Consultation to Increase Guideline-Directed Medical Therapy for Heart Failure: A Pilot Randomized Trial	9
Unmasking Transthyretin Cardiac Amyloidosis Following Transcatheter Aortic Valve Implantation	9
Practice Patterns After Return of Rare Variants Associated With Cardiomyopathy in the Electronic Medical Records and Genomics Network	9
Clinical Management and Transplant Considerations in Pediatric Pulmonary Hypertension Due to Left Heart Disease: A Scientific Statement From the American Heart Association	9
Prognostic Role of Prior Heart Failure Hospitalization Among Patients Hospitalized for Worsening Chronic Heart Failure	9
Optical Coherence Tomography in Cardiac Allograft Vasculopathy	9
Is It Primetime for Finerenone in Heart Failure?	9
Letter by DeFilippis et al Regarding Article, “Sex Disparities in the Management and Outcomes of Cardiogenic Shock Complicating Acute Myocardial Infarction in the Young”	9
Response by Viray et al to Letter Regarding Article, “Role of Pulmonary Artery Wedge Pressure Saturation During Right Heart Catheterization: A Prospective Study”	9
Letter by Haddy Regarding Article, “Invasive and Echocardiographic Characteristics of a Patient With Severe Pulmonary Valve Regurgitation Pretending Severe Pulmonary Stenosis”	9
Variation in Left Ventricular Assist Device Postdischarge Caregiver Requirements: Results From a Mixed-Methods Study With Equity Implications	9
Hospital at Home as a Treatment Strategy for Worsening Heart Failure	9
Mixed Shock Complicating Cardiogenic Shock: A Corollary or a Ramification?	8
Association of Patient Reported Outcomes With Caregiver Burden in Older Patients With Advanced Heart Failure: Insights From the SUSTAIN-IT Study	8
Nonischemic Cardiomyopathy With Myocardial Calcinosis Masquerading as Cardiac Amyloidosis	8
Obesity and Outcomes Following Cardiogenic Shock Requiring Acute Mechanical Circulatory Support	8
Mineralocorticoid Receptor in Smooth Muscle Contributes to Pressure Overload–Induced Heart Failure	8
Health-Related Quality of Life in Older Patients With Heart Failure From Before to Early After Advanced Surgical Therapies: Findings From the SUSTAIN-IT Study	8
Nonsense Variant PRDM16-Q187X Causes Impaired Myocardial Development and TGF-β Signaling Resulting in Noncompaction Cardiomyopathy in Humans and Mice	8
Impact of Arteriovenous Fistula Compression on Mitral Regurgitation Severity	8
Proteomic Associations of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) in Heart Failure With Preserved Ejection Fraction	8
Hemodynamic Effects of Sacubitril-Valsartan Versus Enalapril in Patients With Heart Failure in the EVALUATE-HF Study	8
Letter by ten Berg et al Regarding Article, “Early Serial Assessment of Aggregate Vasoactive Support and Mortality in Cardiogenic Shock: Insights From the Critical Care Cardiology Trials Network Regis	8
Failing to Make the Grade: Conventional Cardiac Allograft Rejection Grading Criteria Are Inadequate for Predicting Rejection Severity	8
Use of a Pulmonary Artery Pressure Sensor to Manage Patients With Left Ventricular Assist Devices	8
Estimation of Right Atrial Pressure by Ultrasound-Assessed Jugular Vein Distensibility in Patients With Heart Failure	8
Cannabis Use and Heart Transplantation: Disparities and Opportunities to Improve Outcomes	8
Risk of Worsening Heart Failure and All-Cause Mortality Following COVID-19 Vaccination in Patients With Heart Failure: A Nationwide Real-World Safety Study	7
Blood Pressure and Glycemic Control Among Ambulatory US Adults With Heart Failure: National Health and Nutrition Examination Survey 2001 to 2018	7
Diuretic Changes, Health Care Resource Utilization, and Clinical Outcomes for Heart Failure With Reduced Ejection Fraction: From the Change the Management of Patients With Heart Failure Registry	7
Serum Chloride and the Response to Acetazolamide in Patients With Acute Heart Failure and Volume Overload: A Post Hoc Analysis From the ADVOR Trial	7
Increased Chamber Resting Tone Is a Key Determinant of Left Ventricular Diastolic Dysfunction	7
Quality of Life Trajectory and Its Mediators in Older Patients With Acute Decompensated Heart Failure Receiving a Multi-Domain Rehabilitation Intervention: Results From the Rehabilitation Therapy in O	7
Current Approach to the Diagnosis of Sarcopenia in Heart Failure: A Narrative Review on the Role of Clinical and Imaging Assessments	7
Patterns of Referral and Postdischarge Utilization of Cardiac Rehabilitation Among Patients Hospitalized With Heart Failure: An Analysis From the GWTG-HF Registry	7
Defects in the Proteome and Metabolome in Human Hypertrophic Cardiomyopathy	7
Impact of Advanced Therapy Centers on Characteristics and Outcomes of Heart Failure Admissions	7
Should We Be Using Aortic Pulsatility Index Over Cardiac Power Output in Heart Failure Cardiogenic Shock?	7
ERBB4 and Multiple MicroRNAs That Target ERBB4 Participate in Pregnancy-Related Cardiomyopathy	7
Impact of Rapid Up-Titration of Guideline-Directed Medical Therapies on Quality of Life: Insights From the STRONG-HF Trial	7
Coronary Microvascular Dysfunction in Patients With Heart Failure: Characterization of Patterns in HFrEF Versus HFpEF	7
Dapagliflozin Improves Heart Failure Symptoms and Physical Limitations Across the Full Range of Ejection Fraction: Pooled Patient-Level Analysis From DEFINE-HF and PRESERVED-HF Trials	6
Neurohormonal and Renal Effects of 14-Day Oral Ketone Ester Treatment in Patients With Heart Failure With Reduced Ejection Fraction	6
Factors Associated With Racial and Ethnic Diversity Among Heart Failure Trial Participants: A Systematic Bibliometric Review	6
Overexpression of ATP5F1A in Cardiomyocytes Promotes Cardiac Reverse Remodeling	6
Racial Differences in Donor-Derived Cell-Free DNA and Mitochondrial DNA After Heart Transplantation, on Behalf of the GRAfT Investigators	6
Contemporary Management of Cardiogenic Shock: A RAND Appropriateness Panel Approach	6
Endovascular Treatment of Flow-Limiting Iliofemoral Stenosis Improves Left Ventricular Diastolic Function in Patients With HFpEF by Reducing Aortic Pulsatile Load	6
NAD + Redox Imbalance in the Heart Exacerbates Diabetic Cardiomyopathy	6
Adoption of Sacubitril/Valsartan Among Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The Get With The Guidelines-Heart Failure Registry	6
Impact of Heart Transplant Allocation Change on Waitlist Mortality and Posttransplant Mortality in Patients With Left Ventricular Assist Devices	6
Prevalence and Incidence of Heart Failure Among Urban Patients in China: A National Population-Based Analysis	6
Enhanced Expression and Function of Renal SGLT2 (Sodium-Glucose Cotransporter 2) in Heart Failure: Role of Renal Nerves	6
The Association of Protein Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction	6
The Value of Passive Leg Raise During Right Heart Catheterization in Diagnosing Heart Failure With Preserved Ejection Fraction	6
Incidence and Outcomes of Advanced Heart Failure in Adults With Congenital Heart Disease	6
Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF Trial	6
Acute Heart Failure Caused by Rupture of Sinus of Valsalva Into Right Atrium in a Patient With Possible Infective Endocarditis After Tricuspid Annuloplasty: A Misdirected Clinical Decision-Making	5
Trimethylamine N -Oxide and Related Gut Microbe-Derived Metabolites and Incident Heart Failure Development in Community-Based Populations	5
Quality of Life and Exercise Capacity in Early Stage and Subclinical Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH Trial	5
Inhibition of Pyk2 Improves Cx43 Intercalated Disc Localization, Infarct Size, and Cardiac Function in Rats With Heart Failure	5
Pseudo-Severe Mitral Stenosis From Obesity-Related HFpEF and Atrial Myopathy	5
Diagnosis and Treatment of Right Heart Failure in Pulmonary Vascular Diseases: A National Heart, Lung, and Blood Institute Workshop	5
Reversible Cause of Heart Failure?	5
Use of a Cardiac Scale to Predict Heart Failure Events: Design of SCALE-HF 1	5
Improving Upon the Ice Ages: Is SherpaPak the Solution?	5
Redefining Cardiac Antibody-Mediated Rejection With Donor-Specific Antibodies and Graft Dysfunction	5
Home Hemodynamic Monitoring to Guide Reduction of Persistently High Pulmonary Artery Pressures in Chronic Heart Failure	5
Testosterone, Hypogonadism, and Heart Failure	5
Mixed Shock Complicating Cardiogenic Shock: Frequency, Predictors, and Clinical Outcomes	5
Response by Aronson et al to Letter Regarding Article, “Enhancing Sweat Rate Using a Novel Device for the Treatment of Congestion in Heart Failure”	5
Gut Hormones in Heart Failure	5
Correction to: Pulmonary Artery Pressure-Guided Heart Failure Management Reduces Hospitalizations in Patients With Chronic Kidney Disease	5
Inflammatory Glycoprotein 130 Signaling Links Changes in Microtubules and Junctophilin-2 to Altered Mitochondrial Metabolism and Right Ventricular Contractility	5
Multimarker Analysis of Serially Measured GDF-15, NT-proBNP, ST2, GAL-3, cTnI, Creatinine, and Prognosis in Acute Heart Failure	5
One-Year Outcomes Following Heart Transplantation Under the New Donor Heart Allocation System in the United States	5
Antithrombotic Therapy for Mechanical Circulatory Support: Time to Throw the Baby (Warfarin) Out With the Bathwater (Aspirin)?	5
Myocardial Inflammation in Cardiac Transthyretin Amyloidosis: Prevalence and Potential Prognostic Implications	5
Letter by Shah Regarding Article, “Reversible Cause of Heart Failure?”	5
Temporal Trends and Clinical Trial Characteristics Associated With the Inclusion of Women in Heart Failure Trial Steering Committees: A Systematic Review	5
Search for Biomarkers to Discern Risk in Worsening Renal Function During Acute Heart Failure	5
Cardiac and Noncardiac Disease Burden and Treatment Effect of Sacubitril/Valsartan	5
Peripheral Venous Pressure+Fenestration Doppler=Noninvasive Cardiac Catheterization Post-Fontan	5
Avoidable Hospitalization for Heart Failure Among a Cohort of 18- to 64-Year-Old Italian Citizens and Immigrants: Results From the Italian Network for Longitudinal Metropolitan Studies	4